![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Glenmark Life Sciences Limited Mumbai In, based in India, is a pharmaceutical company.
One of their significant offerings is Zolpidem tartrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2007-102 - Rev 04
This Chemical Type CEP, issued on December 05, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1280 associated with this CEP further emphasizes